Study reveals racial and socioeconomic disparities in lung cancer testing
A new Mount Sinai study published in the Journal of the National Cancer Institute on September 10, 2024, has found that ...
The Healthy on MSN1d
‘Here’s How I Knew I Had Lung Cancer’: One Patient’s Story with Relatively Low Risk Factor
It's not only due to smoking, as this survivor's story might help demonstrate—says one expert doctor: "All you need to be at ...
FDA Okays J&J's RYBREVANT For Advanced Non-Small Cell Lung Cancer In Combination With Chemotherapy
Johnson & Johnson (JNJ) announced that the U.S. Food and Drug Administration approved RYBREVANT (amivantamab-vmjw) in combination ...
Cancer fighting jab showing early promise in trials - how does it work?
A vaccine designed to fight cancer cells has shown promising signs in an early trial. Tests are underway to potentially ...
WJCT4d
Report: Cancer diagnoses are more common but so is surviving
A new report shows rapid development of new cancer treatment and detection is helping people live more. But more people are ...
Adjuvant durvalumab extends survival in small cell lung cancer
For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer ...
McLaren Greater Lansing using new tool to diagnose lung cancer earlier, more accurately
There’s a new cancer-fighting tool at McLaren Greater Lansing Hospital that is now allowing doctors to diagnose lung cancer earlier and more accurately. Dr. Salah Aboubakr, the first to use this new ...
Johnson & Johnson's Mid-Stage Lung Cancer Trial Reveals Fewer Infusion-Related Reactions
Johnson & Johnson announced promising Phase 2 SKIPPirr study results for Rybrevant in reducing infusion-related reactions in ...
studyfinds12d
Doctors may have found the best way to keep lung cancer patients from dying
Researchers have unveiled a potential paradigm shift in treatment strategies that could significantly improve patients' ...